Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.

In Haiti, 22 communes still require mass drug administration (MDA) to eliminate lymphatic filariasis (LF) as a public health problem. Several clinical trials have shown that a single oral dose of ivermectin (IVM), diethylcarbamazine (DEC) and albendazole (ALB) (IDA) is more effective than DEC plus A...

Full description

Bibliographic Details
Main Authors: Christine L Dubray, Anita D Sircar, Valery Madsen Beau de Rochars, Joshua Bogus, Abdel N Direny, Jean Romuald Ernest, Carl R Fayette, Charles W Goss, Marisa Hast, Kobie O'Brian, Guy Emmanuel Pavilus, Daniel Frantz Sabin, Ryan E Wiegand, Gary J Weil, Jean Frantz Lemoine
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-06-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0008298

Internet

https://doi.org/10.1371/journal.pntd.0008298

Similar Items